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Abstract
The healthcare industry is primed for a massive transformation in the coming decades
due to emerging technologies such as Artificial Intelligence (AI) and Machine Learning. With a
practical application to the UNOS (United Network of Organ Sharing) database, this Thesis
seeks to investigate how Machine Learning and analytic methods may be used to predict oneyear heart transplantation outcomes. This study also sought to improve on predictive
performances from prior studies by analyzing both Donor and Recipient data. Models built with
algorithms such as Stacking and Tree Boosting gave the highest performance, with AUC’s of
0.6810 and 0.6804, respectively. In this work, a roadmap was created that justifies the need for
these technologies in healthcare. In application, the data was prepared, models were built using
advanced algorithms, and important variables were selected. These steps were continuously done
with validation from experienced clinicians. To yield greater insights in this study, the dataset
was split row-wise by factors such as LVAD Support, Donor/Recipient Gender Combinations,
and Time Period; this rendered 8 new datasets for analysis. This work explores the trade-off
between interpretability and performance in applying analytic methods in a real-world problem
in this domain. Finally, forward looking industry implications are discussed.

Merekar 1

Chapter 1: Introduction
Heart transplantation has been carried out since the 1970s, but still remains one of the
riskiest procedures today. Formally, a heart transplant is defined as the surgical replacement of
the heart of a diseased individual with that of a healthy donor (National Heart, Lung, and Blood
Institute, “Heart Transplant”). Typically, patients who have end-stage heart failure, where the
heart is severely damaged or weakened, undergo this procedure. Heart failure is caused by
conditions such as coronary heart disease, hereditary conditions, and/or viral infections (National
Heart, Lung, and Blood Institute, “Heart Transplant”). A patient in need of a heart transplant can
locate donor organs through the United Network for Organ Sharing. This private, non-profit
organization manages the United States’ organ transplant system and provides a computerized
national waiting list which assures equal access and fair distribution of organs as they become
available (United Network for Organ Sharing, “About UNOS”).
Several risk factors are associated with heart transplantation. The first is primary graft
dysfunction (PGF), which occurs when the donor heart fails and is unable to function (National
Heart, Lung, and Blood Institute, “Risk Factors”). This is an immediate issue and usually leads
to a quick time of death for the patient. It is also a major contributor to mortality and
additionally, may lead other complications (Iyer et al. 1-2). The patient’s immune system may
also reject the newly transplanted heart within the first six months of transplantation. To combat
this, the patient must take additional medicine to suppress the immune system. Long term side
effects associated with this medicine include diabetes, osteoporosis, and kidney damage
(National Heart, Lung, and Blood Institute, “Risk Factors”).
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The presence of technology in healthcare, particularly data science, has begun to emerge
within the past few decades. Professionals are beginning to explore the implications of using data
to provide reliable solutions. Heart transplantation procedures are primed to increase in the
coming years, which will be driven by the aging population in the United States. According to
Primers in Medicine, the number of people older than 65 will “double by 2060” (Gedela et al.
19). Another key trend is heavy investment in AI and Machine Learning. As reported by
Accenture, AI investment by healthcare firms will increase to $6B by 2021 (Collier et al. 2). As
more people are at risk for end-stage heart failure and other diseases, AI and Machine Learning
can be leveraged to increase predictive power for heart transplantation outcomes and disease
detection.
This project aims to use Machine Learning 1 techniques to predict one-year heart
transplantation outcomes using queried data from the UNOS registry from 1990-2016. It also
strives to build on prior studies in this domain. Predictive models are constructed to help
clinicians better understand underlying patterns in Donor and Recipient data. Since the
underlying models will be able to predict the likelihood of a patient’s survival after one year,
they will allow the clinician(s) to take the appropriate course of action for treatment.

1. In this work, the terms Machine Learning and Data Mining are used interchangeably.
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Chapter 2: Background & Additional Context
The imminence of technology within healthcare has grown rapidly and has been a driver
of major industry shifts throughout the past decade. One example of such advancements is the
emergence of AI, specifically, Machine Learning. Formally defined, it is the practice of using
algorithms to build models that learn from any n-number of observations and try to emulate the
underlying pattern of the phenomena (Beam and Kohane 1317). This concept allows the
computer to autonomously make decisions without instructions from the researcher and is better
suited for higher dimensional datasets where relationships may not necessarily be linear (Beam
and Kohane 1317). The following trends emphasize why AI will be prevalent and contribute to
the evolving landscape of healthcare/medicine.
Moving to Performance Based Medicine
The healthcare system in the United States is now moving toward a financial model based
on value rather than volume. The onus is now on delivering excellent population health through
treating patients like members. Rather than accounting for revenue due to patient volume, this
value-based model shows each visit as an expense rather than a source of revenue (Burrill,
“Health Care Outlook for 2019: Five Trends That Could Impact Health Plans, Hospitals, and
Patients”).
This shift will take time, as the current transition has not been entirely smooth. In the
short term, healthcare firms may see financial hits before longer-term costs decrease. Despite
this, the value-based model has been embraced as the best method in lowering healthcare costs
while increasing the quality of care. Since patients are seeking the best care possible, Machine
Learning can be a catalyst in providing that, helping people live healthier lives (NEJM Catalyst,
“What is Value Based Healthcare?”).
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Virtual Visits and Wearables
The general population dreads visiting the doctor, and often, waits until a later date when
the condition has become more severe to visit one. This mentality drives up costs for the patient.
Virtual visits and telehealth serve as a basis to interact with a caregiver without attending the
office. According to Steve Burrill of Deloitte, this technology helps them “see more patients,
deal with rising clinical complexity, and support patients as they take a greater role in their own
care.” There is much room to leverage this practice, as currently, only 14% of caregivers are
utilizing this (Burrill, “Health Care Outlook for 2019: Five Trends That Could Impact Health
Plans, Hospitals, and Patients”).
As the popularity of wearables (e.g., Apple Watch, FitBit) grow, so does the data they
transmit. The Internet of Medical Things (IoMT) is the health spin-off of the Internet of Things.
This phenomenon can be explained as the “collection of medical, drug delivery devices and
applications that connect to healthcare IT systems through online computer networks” (D et al.
290). Medical devices equipped with Wi-Fi allow for machine-to-machine interactions. Such a
phenomenon can help clinicians/healthcare professionals collect data points that may be used for
disease prediction, patient status checks, and drug developments.
Leveraging Artificial Intelligence
Artificial Intelligence lies at the center of all of these trends. For example, in a virtual
visit, software can be used to track a person’s mood. Rather than meeting with someone, data
from a patient’s Electronic Health Record (EHR) can help manage illnesses. Data from
wearables and tracking will be used to predict what a diagnosis may be, what drugs can be
developed to help that will help the patient, and realistic timelines of treatment.
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AI aims to mimic human cognition. Rather than fully replace doctors, it must be used in a
way where professionals are working with AI to enhance clinical decisions. Now, with various
analytic methods and collections of EHR’s, this is becoming a reality. For example, it is already
making waves in radiology, oncology, disease prediction/prevention, and outcome prediction
with AI system IBM Watson. The system includes underlying Machine Learning models but is
also a pioneer in the field. According to Jiang et al., “99% of the treatment recommendations
from Watson are coherent with the physician decisions” (241). Several reviews have appeared in
literature referencing similar analytic methods in healthcare; these have covered techniques,
algorithms, and dataset evaluations. Additionally, research in this space is growing, as the
number of published papers has increased by nearly 300% from 2008 to 2015 (Srivastava et al.
1665). This trend also contributes to the motivation for this study.
Emergence of Big Data in Healthcare
Big data has an incredible potential to yield significant value in healthcare. This will be
driven by decreasing costs of data storage, access to powerful but remote cloud computing,
proliferation of “smart” devices, and the increase in electronic communication. Take for example
healthcare titan Kaiser Permanente, which consists of approximately nine million members. The
firm has the capability to manage up to 44 petabytes of data through its EHR. This is “4,400
times the equivalent of the data stored in the Library of Congress” (Roski et al. 1115). This
implies that there is a vast amount of data readily available for analysis in healthcare.
Big data is typically understood as a combination of three concepts – volume, velocity,
and variety. Volume refers to the amount of data currently present in an enterprise; many experts
assert that “90% of the data (stored)” has been created only over the last eight years (Sherman 4).
Velocity measures the time sensitivity of data; reporting and analysis need to be immediate and
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there is greater pressure to bridge the gap between when the data is acquired and when it is
analyzed. Finally, variety is the idea that data is now collected from many different sources. It
can be structured (e.g., tabular) or unstructured (e.g., emails, documents, PowerPoints). In this
work, these opportunities are taken advantage of, and findings from prior studies are considered.
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Chapter 3: Related Work
As mentioned previously, this project builds on prior studies in the field. Machine
Learning and analytic methods have been explored not only for heart transplantation, but in other
realms of clinical decision making as well. For example, a study was conducted that analyzed the
risk of acute kidney injury (AKI), which is associated with chronic kidney disease and poses a
high risk of mortality (Parreco and Chatoor 725). Another study used machine learning
techniques to predict remission outcomes of Type 2 Diabetes following bariatric surgery
(Johnston et al. 580).
Although these studies are not directly related to heart transplantation, they do have
aspects in common. Those studies, along with this one, are Classification problems where the
response variable is binary, the methodology is relatively similar, and the same evaluation
method of Area Under the Curve (AUC) is utilized. Additionally, a common theme in Machine
Learning studies in healthcare is the Logistic Regression model serves as a baseline for model
comparison.
Moreover, directly related studies have been conducted with the same data in which
Machine Learning was used to predict one-year mortality. One example of a similar study
included a report from the Journal of Cardiac Failure, which compared results from traditional
statistical techniques with more advanced techniques. This study employed six variables: age of
recipient, creatinine, body mass index, liver function tests, aspartate transaminase, and
hemodynamics. With the given variables, models were created with traditional statistical
techniques and machine learning algorithms; these were all evaluated by the metric AUC. The
implementation of Deep Learning models yielded the best AUC, which was roughly 0.66. At the
end, it was deemed that the implementation of more advanced techniques failed to yield an
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improved result when compared to traditional approaches, as there was a modest discrepancy
between the two (Miller et al. 3-4). One possible drawback to this study was that the researchers
only used the recipient data and did not emphasize the donor’s data. The study was also only
limited to univariate variables.
In another similar study, clinicians and data scientists utilized existing models to predict
one-year mortality outcomes. The two models were IMPACT (Index for Mortality Prediction
After Cardiac Transplantation) and IHTSA (International Heart Transplantation Survival
Algorithm) which both implemented Machine Learning and Deep Learning techniques. The
IMPACT model yielded an AUC of 0.608 with 18 variables being used, while the IHTSA model
yielded an AUC of 0.64 with 32 variables (Medved et al. 3-6). One drawback to this study is that
it was ambiguous as to which variables were used when each model was initially created.
Another similar study was carried out where analytic methods were leveraged to predict
mortality outcomes, however, this study addressed a slightly different problem and differed in
overall methodology. Various analytic techniques were still carried out, but this paper considered
one, five, and nine-year mortality instead. To impute missing values for bias removal, the
researchers used Synthetic Minority Oversampling TEchnique (SMOTE) which is used to
“improve random oversampling” (Blagus and Lusa 2). This technique is well suited for lower
dimensional data but is not ideal in higher dimensional settings. The best performance this study
was able to uncover were AUC’s of 0.624, 0.676, and 0.838 for one, five, and nine-year
mortality, respectively (Dag et al. 47-49).
In this study however, Donor and Recipient data will be analyzed through advanced
algorithms to improve overall predictive power in heart transplantation. Additionally, the data
will be split in various ways to potentially yield further insights and variables are to be
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eliminated from the full dataset for interpretability. This is further explained in following
chapters.
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Chapter 4: Data & Methodology
Data mining projects such as these have flexibility to be creative and dynamic. There is,
however, an accepted framework known as CRISP-DM (CRoss Industry Standard Process for
Data Mining) which is independent in industry and technology used. This framework aims to
organize the steps in a data mining project. CRISP-DM has been seen as beneficial for
organizations conducting large data mining projects in terms of cost, reliability, and
manageability. This is the overarching methodology used for this project to keep a rigid structure
and reduce errors. The relevant five elements of this framework are Business Understanding,
Data Understanding, Data Preparation, Model Building, and Evaluation.

Figure 1. Phases of the CRISP-DM Model for Data Mining/Machine Learning. CRISP-DM – a
Standard Methodology to Ensure a Good Outcome - Data Science Central.
https://www.datasciencecentral.com/profiles/blogs/crisp-dm-a-standard-methodology-to-ensure-agood-outcome.
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Business Understanding
The initial phase of the framework involves defining the problem at hand solely from the
perspective of the business. Following this, the problem is converted into one that can be solved
by data mining (Wirth and Hipp 5). In this case, the project lies in the domain of
healthcare/medicine, so that was kept in mind throughout the process. The clearly defined
problem is to understand and predict one-year mortality after a heart transplant.
Data Understanding
The next phase of the framework is understanding the data. This begins with obtaining
data and conducting elementary observations to pick up on any immediate trends. Here, data
quality issues are also identified (Wirth and Hipp 5). The corresponding query from the UNOS
database yields a 32018 by 558 data frame. Each row represents an individual patient, and each
patient has descriptive variables. It was apparent that the quality of the data was not quite up to
par; missing values were present which made conducting initial analyses difficult. The data types
of some variables also were not correct.
Data Preparation
The data preparation phase spans all activities used to create the final data set; the one(s)
that will be used in the model building process. This phase may be repeated many times in a
given project. Some tasks include feature selection, data cleaning, and additional data
transformation. In this project, the data had to be “cleaned” (e.g., adjusting data types, removing
features, dealing with missing values) (Wirth and Hipp 5). One example of an adjusted data type
was the response variable, “One_year_mortality_retransplant”. This had to be changed to a
“factor” data type. According to Python’s pandas documentation, these data types take on a
“limited, and usually fixed, number of possible values.” Missing values were dealt with
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differently depending on the algorithm used to build each model. Cleaning was validated with
clinicians, as they provided more insight for understanding the variables. In this project, the
target variable had categories “Died” or “Has not died” signified by the binary 1 and 0,
respectively. In terms of feature selection, initially, many variables were omitted due to lack of
variability cutting down the count to 420. Feature Selection was used again to reduce the number
of variables to improve interpretability. This is further discussed at the end of the chapter.
Additionally, the data was iteratively prepared by splitting on factors such as time period
of transplant, LVAD support, and Donor/Recipient gender combinations. With respect to time
period, two new datasets were derived based on transplantation dates before and after 2006. For
gender, each donor/recipient combination was analyzed, yielding four new datasets. The four
combinations were male donor/male recipient, male donor/female recipient, female donor/male
recipient, and female donor/female recipient. A Left Ventricular Assist Device (LVAD) is used
when a patient is near heart failure but cannot acquire a transplant immediately. This device is
installed to assume the role of providing blood to vital organs (Gedela et al. 19). Two datasets
were created here to understand how the analyses would change depending on whether the
recipient had an LVAD or not.
Model Building
In this phase, models are built and tested. Usually, there are several techniques that can
be used to create models (Wirth and Hipp 6). The specific algorithms used for this study were
Logistic Regression, Decision Trees/Random Forest, Tree Boosting, Neural Networks (Deep
Learning), and Stacking. Logistic Regression is the most traditional algorithm used in medicine,
so for the purposes of this project, it served as the baseline for comparison. All models were built
using the H2O module in the Python programming language powered by Amazon Web Services.
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Discussion of Relevant Algorithms
1. Logistic Regression
Logistic Regression is a widely used algorithm when the desired outcome is a question of
classification. Rather than modeling a specific response directly, Logistic Regression models the
probability that the desired outcome belongs in a particular category. As the algorithm deals with
probability, the related sigmoidal function must only produce outputs between 0 and 1. Below is
the general logistic function for a multivariate Logistic Regression (see Fig. B in Appendix for
visual representation):
𝑝(𝑋) =

𝑒 𝛽0+𝛽1 𝑋1+⋯+𝛽𝑝 𝑋𝑝
1 + 𝑒 𝛽0+𝛽1𝑋1 +⋯+𝛽𝑝 𝑋𝑝

,

where 𝑋 = (𝑋1 , 𝑋2 , … , 𝑋𝑝 ) are p predictors. In this work, the model derived from this algorithm
served as a baseline for the performance of other “advanced” models (James et. al 130-133).
With respect to models built with Logistic Regression, missing values were filled by mean
imputation.
2. Decision Trees/Random Forest
Decision Tree is a hierarchical structure composed of branches and nodes. These are
essentially a collection of ‘if/else’ statements that split decisions into binary classifications (in
this case, “Died” or “Has not died”). Formally, this algorithm involves stratifying or segmenting
the data set into a number of simple regions and making predictions (James et. al 306-312):
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a. Divide the predictor space (the set of possible values for X1, X2, …, Xp) into J distinct and
non-overlapping regions, R1, R2,…, RJ.
b. Create each binary partition based on node purity. This can be quantified by the Gini
Index, where a pure node would produce a value closer to 0 (𝑝̂𝑚𝑘 represents the
proportion of the kth classification in the mth region):
𝐾

𝐺 = ∑ 𝑝̂𝑚𝑘 (1 − 𝑝̂𝑚𝑘 )
𝑘=1

c. For every observation that falls into the region Rj, the same prediction is made, which is
simply the mode of the response values for the training observations in Rj.
Figure 2. Decision Tree Algorithm. James, Gareth, et al. An Introduction to Statistical Learning.
Springer New York, 2013. DOI.org (Crossref), pp. 306-312, doi:10.1007/978-1-4614-7138-7.

Although decision trees are relatively simple to interpret, their downfall lies in the fact
that they are not robust. A small change in the data can yield quite a large change in the final
estimated tree. To correct this problem, the Random Forest algorithm may be implemented,
which is essentially a large collection of decision trees (Amornsamankul et al. 3). This algorithm
corrects the instability of Decision Trees by bootstrap aggregating and decorrelating trees. This
leads to stronger predictive power and lessens the risk of overfitting, which is touched on later in
this chapter. With these models, missing values were filled by using the mode of respective
variables.
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3. Tree Boosting
Another way to combat Decision Tree instability is by using Boosting. Tree Boosting
(e.g., Gradient Boosting Machine, Extreme Gradient Boosting) is widely used in machine
learning to achieve optimal performance. It is an ensemble method that sequentially creates new
members; the newest member is created to account for incorrectly labeled instances from
previous learners to minimize the loss function (direct relationship to error). The results of new
trees are then applied partially to the entire solution. The algorithm executes M boosting
iterations to learn a function F(x) that outputs predictions ŷ = F(x) while simultaneously
minimizing a loss function L (y, ŷ). At each iteration, a new estimator f(x) is added to correct the
prediction of y for each instance in training. This is shown formally below:

a. Start with a function which approximates the true relationship of x and y:
𝐹𝑚+1 (𝑥) = 𝐹𝑚 (𝑥) + 𝑓(𝑥) = 𝑦
𝑓(𝑥) = 𝑦 − 𝐹𝑚 (𝑥)
b. This fits the model f(x) for the current boosting iteration to the errors above
(difference of actual and predicted). This can be shown as a gradient descent
algorithm when the loss function is the squared error:
𝐿(𝑦, 𝐹(𝑥)) =

1
(𝑦 − 𝐹(𝑥))2
2

c. Let the summation of this loss function be denoted as J. The goal is to minimize J by
adjusting F(xi), the function of a particular instance.
𝐽 = ∑ 𝐿(𝑦𝑖 , 𝐹(𝑥𝑖 ))
𝑖

𝑑𝐽
𝑑(∑𝑖 𝐿(𝑦𝑖 , 𝐹(𝑥𝑖 )))
=
= 𝐹𝑚 (𝑥𝑖 ) − 𝑦𝑖
𝑑𝐹(𝑥𝑖 )
𝑑𝐹(𝑥𝑖 )
d. Thus, errors are equal to the negative gradient of the squared error loss function:
𝑓(𝑥) = 𝑦 − 𝐹𝑚 (𝑥) = −

𝑑(∑𝑖 𝐿(𝑦𝑖 , 𝐹(𝑥𝑖 )))
𝑑𝐹(𝑥𝑖 )

Figure 3. Tree Boosting Algorithm. Mitchell, Rory, and Eibe Frank. “Accelerating the XGBoost Algorithm Using GPU
Computing.” PeerJ Computer Science, vol. 3, July 2017, pp. 3-4. DOI.org (Crossref), doi:10.7717/peerj-cs.127.
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By adding a model that approximates this, the loss function is further minimized (Mitchell and
Frank 3-4).
Often in the building phase, this algorithm will produce the strongest model in all facets
of evaluation as it is inherently robust. Some of the drawbacks to this is that Tree Boosting tends
to overfit but can also be corrected by adjusting tree sizes by pruning (Chen and Guestrin 3-5).
With these models, missing values were filled by using the mode of respective variables.
4. Artificial Neural Networks (Deep Learning)
Neural Networks have recently been adapted as a viable data analytic method. These
networks aim to emulate that of the human brain, as they contain “neurons” (linear or non-linear
computing elements) interconnected in complex ways and organized in layers.
A simple perceptron2 constructs a linear combination of the inputs called the net input.
Thereafter, an activation function is linked to produce an output, this maps any real input to a
bounded range. A functional link network introduces a hidden layer in the network. This uses
nonlinear activation functions to produce a fully nonlinear model (in parameters). The resulting
model is known as an MLP or multilayer perceptron. These models are flexible, general purpose,
and non-linear and have the ability to yield multiple outputs from many inputs. Given enough
data, this can approximate to a desired degree of accuracy. During building, numerical values
were filled by using mean imputation, while categorical ones were omitted. An illustration of a
sample neural network may be found in the Appendix (Fig. C) (Sarle 2-5).
5. Stacking
Stacking is an approach for building up classifier ensembles; this refers to a collection of
classifiers in which their decisions are put together to classify new instances. The algorithm

2. A perceptron is a single-layer Neural Network. An interconnected system of perceptrons (MLP) yields a Neural
Network.
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combines multiple classifiers to induce a higher-level classifier with improved predictive
performance (Sakkis et al. 1-2). In this study, two variants are used. “Best of Family” combines
the best models from each algorithm, and “All Models” merges all models in a given iteration of
building. Missing values were handled by the base algorithms of the ensemble.
Resampling Methods
Generally, in Machine Learning projects, the researcher splits a given dataset into a
training and test set based on a chosen ratio. The training set is used to build models upon, while
the test set acts as a proxy for how the model will perform on future, unseen data. This method,
known as the Hold-Out Method, introduces additional error.
An important concept to understand in this domain is the bias-variance tradeoff
(sometimes also referred to as the tradeoff between data-fit and complexity). The main point of
model building is to showcase that it can generalize to unseen data. Maybe counter-intuitively,
predictive performance is not maximized by learning the training data as precisely as possible.
An extremely close fit to the training data is typically not ideal because the model will pick up
random fluctuations in the data (i.e. noise) and miss the “broader regularities” in the dataset
(Briscoe and Feldman 3-4). Using just the Hold-Out method can lead to high bias, low variance,
or vice-versa. An illustration of the bias-variance tradeoff may be found in the Appendix (Fig.
D).
Alternatively, resampling methods can be defined as iteratively fitting models on
randomly drawn samples of given data. One of these methods, perhaps the most popular, is kFold Cross Validation. The dataset is divided into k folds (row-wise), where each k – 1 folds
become training sets while the remaining fold acts as a test set. An error value is calculated for
the “test” fold, and finally, the average of each test fold becomes the overall error value
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(Rodriguez et al. 569). This was the resampling method of choice for this project, with k = 5. An
illustration may be found below:

Figure 4. K-Fold Cross Validation. Ren, Qiubing, et al. “Tectonic Discrimination of Olivine in
Basalt Using Data Mining Techniques Based on Major Elements: A Comparative Study from
Multiple Perspectives.” Big Earth Data, vol. 3, no. 1, Jan. 2019, p. 14. DOI.org (Crossref),
doi:10.1080/20964471.2019.1572452.

Compared to the simple Hold-Out method, k-Fold Cross Validation has advantages in
both bias and variance. Bias is reduced in the sense that there are more observations “seen” by
the model during training. Variance is also reduced due to the fact that there is smaller overlap
between each training set. Given these considerations, it is empirically proven that k = 5 or k =
10 yield test errors that do not suffer from high bias nor very high variance (James et al. 181184).
Model Evaluation
At this point in the framework, multiple models have been built and are ready to be
compared. The models are constructed correctly and are assumed to be of the best quality
possible. Before deployment of a model, it is vital to thoroughly evaluate each model, review
steps taken to build the model, and justify it using the business context (Wirth and Hipp 6).
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Confusion matrices are used in evaluation of problems of binary classification. It is a 2x2
table formed by counting the number of the four outcomes of a binary classifier. The two
“classes” are actual and predicted with a positive/negative value for each. The four cells are
filled with the number of True Positives (TP), False Positives (FP), False Negatives (FN), and
True Negatives (TN) (Amornsamankul et al. 5).
In this project, the outcomes of “Died” or “Has not died” are examined. True Positives in
this case refer to the number of “Died” predicted when the actual value was also “Died.” False
Positives are the number of “Has not died” predicted when the outcome was actually “Died.”
False Negatives are the number of predicted “Died” when the actual was “Has not died.” True
Negatives are the number of predicted “Has not died” when the actual classification was “Has
not died”. In this case, False Negatives are more costly than False Positives, so the metric of
Sensitivity (Recall) is also relevant in this study.

Predicted Class

Actual Class

Died

Has not died

Died

TP

FP

Has not died

FN

TN

Figure 5. One-year Mortality Confusion Matrix.

From this, prediction accuracy, sensitivity (recall), and specificity may be derived:
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =

𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁

𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 (𝑅𝑒𝑐𝑎𝑙𝑙) =
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =

𝑇𝑃
𝑇𝑃 + 𝐹𝑁

𝑇𝑁
𝑇𝑁 + 𝐹𝑃
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Key Metric: Area Under the Receiver Operating Characteristic Curve (AUC)
The Receiver Operating Characteristic Curve (ROC Curve) has been identified as a
viable solution of visualizing a classifier’s performance in order to select an optimal decision
threshold. The term was coined during World War II when it was used in “Signal Detection
Theory” for radars, but later made its way to diagnostic medicine. It was determined that an
“ideal” threshold is almost always a trade-off between sensitivity (True Positives) and specificity
(True Negatives). Since it may be difficult for a researcher to imagine an ideal “cut-off”, this
concept was visualized. The Y-Axis represents Sensitivity while the X-Axis represents
Specificity. In theory, a researcher would want to achieve both high Sensitivity and Specificity,
but this is far from practical in application. Hence, there is a trade-off, and either one of the two
metrics can be optimized (Bradley 1145).
The area under the ROC Curve (referred to as AUC) is widely recognized as the measure
of a diagnostic test’s discriminatory power. The value of AUC ranges from 0.0 to 1.0, where a
value of 1.0 implies 100% sensitivity and specificity. A value of 0.5 indicates no discriminative
value. This entails 50% sensitivity and 50% specificity (Fan et al. 20). In terms of this project,
ROC curves were visualized for each model, and ranked based on AUC. Models with AUC’s
that performed better than the baseline Logistic Regression were deemed the most useful.
Variable Analysis
As there are greater than 400 variables in the full dataset, only significant variables were
considered in individual variable analyses. Each model produced a list of important variables and
these were brought to clinicians for validation. Additionally, to further drill down the number of
variables, the important variables from the top model from each dataset was taken. These were
then counted up to understand the shared important variables throughout all models.

Merekar 21

Chapter 5: Results
After the methodology was carried out, initial results were obtained for each model per
dataset. These contain the top two models from each dataset, the baseline Logistic Regression,
algorithms, AUC measures, Sensitivity, and dataset dimensions. A detailed table depicting all of
these may be found below.
Table 1. Model Performance by Dataset and Algorithm.

Algorithm

AUC

Sensitivity (Recall)

Full Dataset (32,018 Observations, 420 Variables)
Logistic Regression

0.63683332

0.4190646

Stacking, All Models

0.681168

N/A

Extreme Gradient Boosting

0.680403

0.41853034

Patients with no LVAD (10,912 Observations, 420 Variables)
Logistic Regression

0.57672026

0.45374164

Stacking, All Models

0.65443

N/A

Extreme Gradient Boosting

0.653004

0.41827255

Patients with an LVAD (7,700 Observations, 420 Variables)
Logistic Regression

0.58331451

0.5547305

Stacking, All Models

0.65692

N/A

Extreme Gradient Boosting

0.654315

0.43852264

Patients Recorded Before 2006 (13,406 Observations, 420 Variables)
Logistic Regression

0.61300899

0.57854533

Stacking with All Models

0.674364

N/A

Extreme Gradient Boosting

0.67345

0.41904527

Patients Recorded After 2006 (18,612 Observations, 420 Variables)
Logistic Regression

0.60626572

0.46481952

Stacking, All Models

0.668372

N/A

Extreme Gradient Boosting

0.66386

0.4589736

Merekar 22
Female Donor Female Recipient (2,713 Observations, 420 Variables)
Logistic Regression

0.54148685

0.5008384

Stacking, Best of Family

0.662545

N/A

Extreme Gradient Boosting

0.677088

0.53623605

Female Donor Male Recipient (2,730 Observations, 420 Variables)
Logistic Regression

0.570355

0.47577724

Stacking, Best of Family

0.647494

N/A

Extreme Gradient Boosting

0.635834

0.42375335

Male Donor Female Recipient (2,713 Observations, 420 Variables)
Logistic Regression

0.5310544

0.5507362

Stacking, All Models

0.651886

N/A

Extreme Gradient Boosting

0.664648

0.47671908

Male Donor Male Recipient (11,306 Observations, 420 Variables)
Logistic Regression

0.57988709

0.45201996

Stacking, All Models

0.650807

N/A

Extreme Gradient Boosting

0.647327

0.41651163

After the initial analysis, a subset of the full dataset was taken. The data was filtered on the basis
of important variables from the Extreme Gradient Boosting Algorithm on the full dataset and
models were ran again. The results are displayed below:
Table 2. Model Performance: Full Dataset with Significant Variables and Algorithms.

Full Dataset with Significant Variables (32,018, 25)
Algorithm

AUC

Sensitivity (Recall)

Logistic Regression

0.6603

0.4304224

Stacking, All Models

0.671926

N/A

Extreme Gradient Boosting

0.670706

0.4328194
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Following that, more features were removed to make the model more interpretable. The top 16
variables were chosen based on important variables from the top model from each dataset. These
were the significant variables that were most common throughout all models from all datasets.
The models were run again, and the results are displayed below:
Table 3. Model Performance: Full Dataset with Clinically Significant Variables and Algorithms.

Full Dataset with Clinically Significant Variables (32,018, 16)
Algorithm

AUC

Sensitivity (Recall)

Logistic Regression

0.6284

0.44540313

Stacking, Best of Family

0.6500

N/A

Extreme Gradient Boosting

0.6491

0.46050477

Clinically Significant Variables
Analysis of variables included validation with clinicians. They were able to provide
additional context as to whether or not models included variables that made sense from a
physiological standpoint. The top 16 variables included in the most interpretable model are
displayed on the next page.
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Table 4. Top 16 Clinically Significant Variables with Descriptions.

Top 16 Clinically Significant Variables with Descriptions
Variable

Description

Creatinine of Recipient

Waste product filtered by kidney; a build-up may lead to
cardiovascular disease.

Total Bilirubin of
Recipient

Associated with liver complications; a strong predictor in
heart failure.

Ischemic Time

The time an organ has spent cooling/warming before
transplant.

Most Recent Creatinine
Measurement of Recipient

Most recent evaluation of creatinine levels for a recipient
at the time of listing.

Age of Donor

Median Age: 32 years old

Age of Recipient

Median Age: 55 years old

PVR of Recipient

Pulmonary vascular resistance for recipient measured at
listing.

Right Ventricular Mass of
Donor

Both estimates of the myocardial mass of that ventricle
based on echocardiographic measurements.

Right Ventricular Mass of
Recipient
Systolic Pressure of
Recipient

Pulmonary artery systolic pressure in mm/Hg at
registration.

Predictive Heart Mass
Ratio

Total heart myocardial mass estimated by echocardiogram
of donor divided by that of the recipient.

Albumin Measurement of
Recipient

Albumin measured in the recipient plasma at registration.

Distance

Distance between the donor and the recipient in nautical
miles.

Cardiac Output of
Recipient

Cardiac output of the recipient at registration.

Recipient Waiting Days

Total days on the UNOS waiting list.

GPT Measurement of
Donor

GPT Level measured at time of transplant.
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Chapter 6: Discussion & Insights
After analyzing all datasets, it was apparent that advanced methods such as Tree Boosting
(Extreme Gradient Boosting) and Stacking led to higher AUC’s than the baseline Logistic
Regression. This is because Tree Based algorithms are usually more complex. Although they
may be prone to overfitting, pruning and correctly adjusting the number of trees resolves this
issue. Logistic Regression is simpler to understand and less prone to overfitting, however, may
not always grant optimal predictive performance.
Running the Stacking algorithm on the full dataset yielded the highest AUC of about
0.6810. Although this is significant, Stacking is just a collection of models, and cannot be truly
used for interpretation. This is also why there were no Sensitivity metrics for those models.
Aside from Stacking, Boosting also gave high results. When applied to the full dataset, the model
created from this algorithm had an AUC of roughly 0.6804. In practice however, it would not be
feasible for a cardiologist to assess 420 parameters (variables) when trying to understand the
future of a patient. This brings in the idea of real-world use where models must be interpretable.
When the full dataset was cut down by column, 25 variables remained. These were the most
important variables deemed by the Boosting model ran on the full dataset. All algorithms were
run on that subset of data and the Stacking algorithm yielded an AUC of 0.6719. The Boosting
algorithm was very similar in performance, with a 0.6707 AUC. After counting recurring
variables from all model variable importance plots, analysis was reduced to 16 variables. The
Stacking algorithm gave an AUC of .6500 and the Boosting algorithm gave an AUC of .6491.
This would be far more interpretable for clinicians as the parameters were brought down to only
16 variables. Some performance is lost, but the difference is marginal (Fig. 6).
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Figure 6. Visual Depiction of Trade-off Between Performance and Interpretability for Boosting Models.
Average AUC on the Y-Axis corresponds to the average of the Top 2 models from the Full Dataset, Full
Dataset with Significant Variables, and Full Dataset with Clinically Significant Variables.

The prior studies discussed in Chapter 3 did not achieve an AUC greater than 0.66 when
using advanced learning techniques. Through optimal parameter tuning, the Tree Boosting
algorithms were able to achieve higher performance. In those studies, however, the trend was
leaning towards Deep Learning being a long-term solution in this field. In this study, running the
Deep Learning algorithm on the full dataset only produced an AUC of 0.5706. This could have
been again, due to data quality issues as neural networks do not perform well on rather sparse
datasets. Even after cleaning, the data was not suitable to implement an effective Deep Learning
model.
From a clinical standpoint, the aforementioned variables are reasonable to build models
with going forward. Creatinine levels are often greater in patients that are hospitalized with heart
failure, which validates this variable as a driver of mortality (Smith et al. 14). Liver function
abnormalities such as high levels of Total Bilirubin are also associated with higher morality (van
Deursen et al.). Age of Recipient is a good indicator of mortality; older people generally have
poorer health. Ischemic time and Age of Donor are also reasonable because these represent
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worse organ quality. Multiple studies have deemed that age is an independent risk factor for
mortality and argued that longer ischemic times are associated with higher mortality outcomes
(Kilic et al.).
Another point to analyze is the comparisons of the row-wise dataset splits. Comparing the
LVAD support datasets, it was apparent that there was not much of a difference between
performance of those top models. The same can be said for time period, but models run on
observations before 2006 yielded a marginally higher AUC. For Donor/Recipient gender
combinations, it was found that the dataset containing Female Donors and Female Recipients
gave an AUC of 0.6770. This exceeded the performance of all other Donor/Recipient gender
combinations.
Although the models ran on the row-wise splits did not perform better than models from
the full dataset with respect to AUC, they are useful in terms of Sensitivity. Albeit not discussed
as thoroughly as AUC, it is meaningful to analyze this metric in clinical decision making because
in this case, False Negative Cases would be costly. The Tree Boosting model for the full dataset
produced a Sensitivity of about .42. After running that algorithm on the Donor/Recipient gender
combinations datasets, the average Sensitivity of the four was .463. Comparing those two
metrics, Sensitivity of Donor/Recipient gender combinations saw an increase in Sensitivity by
8% on average. This supports the claim that Donor/Recipient gender combinations add value in
clinical decision making (see Fig. H in Appendix).
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Chapter 7: Conclusion
This project aimed to leverage Machine Learning techniques to predict one-year
mortality after a heart transplant. Predictive models were constructed to help clinicians better
understand underlying patterns in data from Donors and Recipients. This way, correct procedures
for treatment may be taken from a medicinal standpoint. This study was continuously validated
by clinicians, from Data Preparation to Evaluation. The data was split based on clinical factors
such as LVAD Support, Donor/Recipient Gender Combinations, and Time Period of Transplant.
Finally, specific features were selected based on the clinician’s ability to interpret the created
models.
As mentioned previously, performance and interpretability vary inversely. This trade-off
is important to understand in deployment. From the analysis done in this work, the Extreme
Gradient Boosting model applied to the full dataset with 25 variables is the optimal one. It serves
as a “middle-ground” between AUC and number of variables. This model performed better than
those from prior studies and uses 25 variables. Although it is not the most interpretable, the
model will perform similarly when exposed to future, unseen data.
Essentially, there are two schools of thought. The data scientist wants to optimize model
performance, while the clinicians strive for the simplest model to understand. To that end, from a
clinical standpoint, the model with 16 variables may be the most optimal. There is a modest
discrepancy in AUC when compared to the model with 25 variables, and theoretically, the
clinician would trade marginal model performance for interpretability. The system needs to be
fed with new data and using 16 parameters rather than 25 is more convenient, easier to
track/measure, and simpler to enforce data integrity constraints upon.
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Chapter 8: Implications
The last phase in the CRISP-DM Framework is Deployment of a selected model. Rarely,
creation of the model is not the end of the project as it still needs to be rolled out on a system,
maintained, and updated periodically (Wirth and Hipp 7). It is important to continuously validate
models built throughout the framework. By doing this, data scientists will be able to gain insight
on whether or not models fit the context of the problem.
Although there is a need for the AI in healthcare as highlighted previously, there are a
few pertinent issues when it comes to deployment and industry-wide adoption of these systems.
Data Privacy
Data is essential for AI and model training, but some patients may be unwilling to give
other entities access to private records. Besides for training, a large data supply is needed for
validation and improvement of these models. For widespread deployment, this sensitive data
must be shared among numerous institutions. To combat this, these EHR’s must be anonymized
and patients would need to be fairly informed. The shift to value-based care will support this, and
further incentivize organizations to collect and ethically maintain this data for analysis (He et al.
31).
Data Standardization
From a data science standpoint, this is an important aspect to consider. Data
standardization refers to the process of transforming data into a common format to be used for
analysis. This way, it can be understood regardless of tools and methodologies (He et al. 33). In
practice, data is collected in many different ways. It is stored in a variety of formats, databases,
and information systems. Although this data may be formatted a certain way in one organization,
if it is shared, another organization may not be able to properly interpret this for analysis. With
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the complexity and volume of healthcare data in particular, this should occur in the initial phases
of model development, even before the CRISP-DM Framework is carried out.
Existing Workforce
There has been significant concern throughout multiple industries of Artificial
Intelligence eliminating the need for human workers. Although some jobs have potential to be
automated, this will likely limit overall job loss. In healthcare, costs of automation technologies
and regulatory and social acceptance are some reasons as to why this may be curbed (Davenport
and Kalakota 96).
To overcome these aforementioned challenges, the workforce itself must understand that
AI is not here to replace it. Instead, the workforce will be able to leverage it to augment existing
workflows and decision making. For an industry-wide implementation, healthcare professionals
must develop trust for these systems. Similarly, the onus is on patients to trust institutions to
handle their data ethically in hopes of improving their own outcomes.
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Chapter 9: Limitations & Future Directions
There are a few limitations this research has faced, the first being the time period of the
queried data. The UNOS Data spans from 1990-2016 and does not take into account records after
that. With the increased importance of data collection in the space, it is reasonable to assume that
future records will follow specific constraints. This entails that the data will contain less errors,
yielding a more thorough analysis. The second limitation would be the interpretation of the
variables in the full dataset. These are generally subjective since there are over 400, so another
set of clinicians could have understood these variables from a different perspective than in this
study. Finally, although discussed thoroughly, it was impossible to complete the CRISP-DM
Framework. The optimal model was limited to simulation and could not be deployed in a real use
case.
For future studies, researchers will be able to leverage “cleaner” data from UNOS as data
standards begin to conform. Aside from that, some questions are posed to future data
scientist/clinician teams that have not been explored in this study:
Can mortality be predicted independent of time period?
This is particularly significant as this project was limited to one-year mortality. If this
limitation was removed, clinicians would be able to understand what may contribute to
shorter/longer mortality periods.
How robust will these models be? How will they scale?
Models must adapt to rapid change as new data is collected. Another point to examine
would be identifying how these models would scale. This is useful from a data science
perspective, and with the emergence of enterprise-wide data and cloud computing, analytic
solutions (e.g. Random Forest, Tree Boosting) have potential to scale rather well.
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Appendix

Figure A. Detailed Overview of the CRISP-DM Framework. Wirth, Rüdiger, and Jochen Hipp.
CRISP-DM: Towards a Standard Process Model for Data Mining. p. 6.
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Figure B. Sigmoidal Function in Logistic Regression. Note, the minimum value is 0 and the
maximum value is 1. Logistic Regression Theory for Practitioners - Towards Data Science.
https://towardsdatascience.com/the-data-scientists-field-guide-to-logistic-regression-part-1intuition-97084b11bd68. Accessed 16 Apr. 2020.

Figure C. Sample Artificial Neural Network. Management AI: Types Of Machine Learning Systems.
https://www.forbes.com/sites/davidteich/2018/07/06/management-ai-types-of-machine-learningsystems/#390b5ba832fb. Accessed 16 Apr. 2020.
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Figure D. Bias-Variance Tradeoff. Bias and Variance in Machine Learning - Data Driven Investor Medium. https://medium.com/datadriveninvestor/bias-and-variance-in-machine-learning-51fdd38d1f86.
Accessed 16 Apr. 2020.

F
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Figure E. ROC Curve from Extreme Gradient Boosting Model Applied to Full Dataset.

F

Figure F. ROC Curve from Extreme Gradient Boosting Model Applied to Full Dataset with Significant Variables.

F

Figure G. ROC Curve from Extreme Gradient Boosting Model Applied to Full Dataset with Clinically Significant Variables.
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SENSITIVITY MEASURES FOR TREE
BOOSTING

XGBoost Recall Averages for Full Datasets
(No Row Splits)

0.42567487

XGBoost Recall Averages Donor/Recipient
Gender Combinations

0.463305028

0.4

0.41

0.42

0.43

0.44

0.45

0.46

SENSITIVITY (RECALL)
Figure H. Sensitivity Comparisons: Full Datasets and Donor/Recipient Gender Combinations.

F

0.47
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